uniQure
QURE
$5.01
Share price
-1.18%
Change (1 day)
-75.63%
Change (1 year)
Market capitalization of uniQure (QURE)
Market cap: $0.24 Billion
As of May 2024 uniQure has a market cap of $0.24 Billion. This makes uniQure the world's 6793th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of uniQure from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.24 B | -24.85% |
| 2023 | $0.32 B | -69.5% |
| 2022 | $1.06 B | 10.73% |
| 2021 | $0.95 B | -40.38% |
| 2020 | $1.60 B | -48.68% |
| 2019 | $3.13 B | 190.99% |
| 2018 | $1.07 B | 78.41% |
| 2017 | $0.60 B | 328.64% |
| 2016 | $0.14 B | -65.02% |
| 2015 | $0.40 B | 50.23% |
| 2014 | $0.26 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of uniQure was reported to be:
$0.24 Billion
$0.24 Billion
$0.24 Billion
$0.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $167.61 B | 68,813.42% | 🇺🇸 USA |
 Sanofi SNY | $122.00 B | 50,061.82% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $0.13 B | -44.58% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.19 B | -18.38% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.72 B | 5,954.74% | 🇺🇸 USA |
 Avidity Biosciences RNA | $2.82 B | 1,059.91% | 🇺🇸 USA |